Orchard Therapeutics

NASDAQ: ORTX · Real-Time Price · USD
16.70
0.05 (0.30%)
At close: Jan 23, 2024, 10:00 PM

Orchard Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
PE Ratio
-6.01 -4.5
PEG Ratio
0.08 0.06
PS Ratio
6.78 338.78
PB Ratio
0.48 0.78
P/FCF Ratio
-0.57 -1.28
P/OCF Ratio
-0.62 -1.31
OCF/S Ratio
-10.88 -259
Debt / Equity Ratio
0.59 0.28
Quick Ratio
2.72 6.39
Current Ratio
2.78 6.43
Asset Turnover
0.03 0.00
Interest Coverage
-33.86 -53.32
Return on Equity
-0.08 -0.17
Return on Assets
-0.04 -0.11
Return on Invested Capital
-0.16 -0.13
Dividend Yield
n/a n/a
Payout Ratio
n/a n/a
Gross Profit Margin
0.65 0.53
Net Profit Margin
-1.13 -75.26
Pretax Profit Margin
-1.29 -75
Operating Profit Margin
-4.52 -75.39
FCF Margin
n/a n/a
EBITDA Margin
-1.16 -73.58